Luba Greenwood is a distinguished executive, investor, and company builder with over 20 years of leadership in healthcare and technology, and extensive global board experience. She is the CEO of Gallop Oncology, a clinical stage biotech. She has founded and served as Managing Partner of Dana Farber Cancer Institute venture fund, and CEO and board chair of multiple life sciences companies including Kojin Tx. She is an Entrepreneur-in-Residence at PureTech, where she plays a key role in advancing oncology programs. Luba has a proven track record of building world-class teams and companies, leading over $15B in deals and investments across therapeutics, diagnostics, and life sciences globally. She has held leadership roles at Google (Verily) and Roche, where as VP of Global Business Development & M&A, she spearheaded diagnostics BD and established the East Coast Innovation Hub. Recognized as an industry thought leader, she advises CEOs of top academic institutions, including Dana-Farber Cancer Institute and Wyss Center. She serves on the Investor Committee for National Cancer Institute and contributes to NEJM Catalyst. Luba is a strategic leader in digital transformation, AI, M&A, financing, and governance, with expertise in scaling companies, guiding high-impact transactions, and driving innovation at the intersection of biotech and technology. A former lawyer at WilmerHale, Luba is an expert in regulatory, IP, and corporate law. She has served as a Harvard University lecturer and sits on multiple public and private boards, including In8Bio, BenchSci, Stalicla, Abcam (where she led its sale to Danaher), Closed Loop Medicine, and MassBio.

Matteo Lai is co-founder and CEO of Empatica, an AI and medical devices company based in Cambridge, Massachusetts and Milan, Italy. Empatica has developed Embrace, the world’s smallest and most accurate wearable sensor suite for research, and become the world’s first FDA cleared smart watch for use in Neurology. Matteo studied Engineering and trained as an Architect, holds a Double MSc degree in Architecture and a Master in Innovation Management.

Sarah Lindenauer is a Product & Portfolio Manager within the Innovation and Digital Health Accelerator (IDHA) at Boston Children’s Hospital. She is focused on accelerating digital health technologies through the development pipeline from inception through commercialization. She is also responsible for managing the accelerator portfolio of innovations. She enjoys working with clinicians and entrepreneurs to build and scale market-competitive technologies for patient impact. Prior to joining Boston Children’s, Sarah worked as a digital strategist for InVentiv Health, consulting to biopharmaceutical and medical device companies on the development of digital adherence and disease education programs. Before that, Sarah worked for a digital health start-up, where she developed a multi-disciplinary framework for the evaluation of third party health applications and advised product managers regarding the optimization of user experience for behavior change. Sarah received both her Master’s in Public Health and her undergraduate degree from the University of Michigan in Ann Arbor.

Nathan Treloar is President and Co-founder of Orbita. He’s a respected expert and frequent speaker on consumer and business trends in voice and conversational user experiences in healthcare, as well as search, text and data mining, content management, and knowledge management, and has advised hundreds of the world’s largest companies and government agencies on their applications. Previously, Nathan held key executive positions at FAST Search, Microsoft, RAMP, and Ektron.